James F. Polewaczyk - Dec 7, 2023 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Signature
/s/ Lily J. Lu, Attorney-in-Fact for James F. Polewaczyk
Stock symbol
IDXX
Transactions as of
Dec 7, 2023
Transactions value $
-$3,116,855
Form type
4
Date filed
12/8/2023, 05:00 PM
Previous filing
Aug 31, 2023
Next filing
Feb 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $1.03M +4.96K +49.31% $206.94 15K Dec 7, 2023 Direct F1
transaction IDXX Common Stock Options Exercise $1.93M +6.68K +44.52% $288.78 21.7K Dec 7, 2023 Direct
transaction IDXX Common Stock Sale -$1.62M -3.12K -14.37% $520.19 18.6K Dec 7, 2023 Direct F2
transaction IDXX Common Stock Sale -$1.76M -3.38K -18.19% $521.00 15.2K Dec 7, 2023 Direct F3
transaction IDXX Common Stock Sale -$628K -1.2K -7.91% $522.31 14K Dec 7, 2023 Direct F4
transaction IDXX Common Stock Sale -$2.06M -3.94K -28.16% $523.56 10K Dec 7, 2023 Direct F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Non-Qualified Stock Option (right-to-buy) Options Exercise $0 -4.96K -86.78% $0.00 755 Dec 7, 2023 Common Stock 4.96K $206.94 Direct F6
transaction IDXX Non-Qualified Stock Option (right-to-buy) Options Exercise $0 -6.68K -75.01% $0.00 2.23K Dec 7, 2023 Common Stock 6.68K $288.78 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 12 shares purchased under the Issuer's Employee Stock Purchase Plan on September 29, 2023.
F2 Represents the weighted average price of the shares sold ranging from a low of $519.73 to a high of $520.73 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F3 Represents the weighted average price of the shares sold ranging from a low of $520.74 to a high of $521.235 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F4 Represents the weighted average price of the shares sold ranging from a low of $521.99 to a high of $522.935 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F5 Represents the weighted average price of the shares sold ranging from a low of $523.05 to a high of $523.885 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F6 Grant of option to buy 5,711 shares of Issuer common stock that vest in five annual installments beginning February 14, 2020.
F7 Grant of option to buy 8,906 shares of Issuer common stock that vest in four annual installments beginning February 14, 2021.